Related Experiment Video
Updated: May 24, 2026
06:33
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
[Conjunctival myeloid sarcoma in acute myeloblastic leukemia-M1]
P Méndez-Cepeda1, A C Millán-Rodríguez, E Dios
1Servicio de Oftalmología, Complexo Hospitalario de Pontevedra, Pontevedra, España. pmendezcepeda@gmail.com
Archivos De La Sociedad Espanola De Oftalmologia
|March 20, 2012
Summary
Extramedullary myeloid sarcoma, a rare leukemia recurrence, can manifest in the eye. This ocular presentation in a leukemia patient indicated a poor prognosis and rapid progression to fatal multiorgan failure.
Area of Science:
- Ophthalmology
- Hematology
- Oncology
Background:
- Acute myeloblastic leukemia (AML) can recur outside the bone marrow.
- Ocular involvement in leukemia recurrence is uncommon but significant.
Observation:
- A 69-year-old male with AML-M1 presented with conjunctival injection.
- Ophthalmological examination identified lesions on the conjunctiva of both eyes.
- Histological and immunohistochemical analyses confirmed myeloid sarcoma.
Findings:
- Conjunctival myeloid sarcoma represents an extramedullary recurrence of leukemia.
- The patient experienced rapid disease progression.
Implications:
- Ocular myeloid sarcoma indicates a grave prognosis in leukemia patients.
- Early recognition of ocular manifestations is crucial for managing leukemia recurrence.
